SWFI First Read, February 28, 2018
Posted on 02/28/2018
Temasek Invests in Viela Bio Gaithersburg, Maryland-based Viela Bio has incorporated as an independent inflammation- and autoimmunity-focused biotechnology company after spinning out six molecules from MedImmune, the global biologics research and development arm of AstraZeneca. Viela Bio raised US$ 250 million from an investor group led by Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital, […]
- Abu Dhabi Investment Authority
- Alternatives
- China
- HNA Group
- North America
- Penske
- PIF
- Rolling Stones
- Temasek
- Temasek Holdings
